✦ LIBER ✦

Effect of a high induction dose (10 MU/TIW) of α-interferon (α-IFN) compared to a 5 MU/TIW dose in the treatment of chronic hepatitis C: an interim report

✍ Scribed by L. Puglisi; A. Buzzi; A. Matera; P. Marino; M. Pompili; GL Rapaccini; A. Grieco; G. Gasbarrini

Book ID: 118568439
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 166 KB
Volume: 28
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(98)80671-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Low dose ribavirin for six months plus i

Low dose ribavirin for six months plus interferon 5 MU TIW for 1 year is effective in the treatment of hepatitis C patients who were initially either relapsers or non-responders to interferon monotherapy

✍ Bernstein, David E.; Jeffers, Lennox; Lake-Bakaar, Gerard 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 161 KB

Induction doses of interferon-α-2a in co

Induction doses of interferon-α-2a in combination with ribavirin and/or amantadine for the treatment of chronic hepatitis C in non-responders to interferon monotherapy: a randomized trial

✍ J. Salmerón; M. Diago; R. Andrade; R. Pérez; R. Solá; M. Romero; M. De La Mata; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 542 KB

[655] PEG-IFN ALFA-2a PLUS RIBAVIRIN IS

[655] PEG-IFN ALFA-2a PLUS RIBAVIRIN IS SUPERIOR COMPARED TO HIGH DOSE CONSENSUS INTERFERON (CIFN) AND RIBAVIRIN IN THE TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C

✍ T. Witthoeft; M. Fuchs 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Randomized trial of high-dose interferon

Randomized trial of high-dose interferon-α-2b combined with ribavirin in patients with chronic hepatitis C: Correlation between amino acid substitutions in the core/NS5A region and virological response to interferon therapy

✍ Nami Mori; Michio Imamura; Yoshiiku Kawakami; Hiromi Saneto; Tomokazu Kawaoka; S 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 275 KB 👁 1 views

## Abstract The aim of this study was to compare the efficacy of high‐dose interferon (IFN)‐α‐2b with standard dose of IFN‐α‐2b in combination with ribavirin (RBV) for patients with chronic hepatitis C virus (HCV) infection, and to investigate the predictive factors associated with virological resp